Gemmothérapie Capital Osseux
Food supplement declared in France, declaration No 2019-8-125, decision dated 2 August 2019
Gemmothérapie Capital Osseux (AROMAYA) is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- AROMAYA
- Food business operator placing the product on the market
- SIRIUS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 360 mg
- Directions for use
- 15 gouttes par jour, pures ou diluées
- Not recommended (according to the manufacturer)
- Allergy to salicylate derivatives
- Objectives stated by the manufacturer (these are not authorised claims)
- Bones
Declaration 165092, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Sequoiadendron giganteum (Lindl.) J.Buchholz | Jeune pousse | Autre macérât | 23 mg |
| Betula pendula Roth | Bourgeon | Autre macérât | 11 mg |
| Pinus mugo Turra | Bourgeon | Autre macérât | 6 mg |
| Rubus fruticosus L. | Jeune pousse | Autre macérât | 6 mg |
Additives
E422
Other ingredients
Alcool, eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose journalière recommandée. Ce produit est un complément alimentaire et ne se substitue pas à un mode de vie sain, ni à une alimentation variée et équilibrée, ni à un suivi médical. Tenir hors de portée des enfants. Peut-être utilisé chez les femmes enceintes et allaitantes sous avis médical. Déconseillé aux personnes souffrant d’allergie aux dérivés salicylés. Conserver le flacon dans son étui, dans un endroit frais et sec, à l’abri de la lumière. Un dépôt naturel peut être visible, mais n’altère en rien la qualité du produit.
Regulatory points
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : AROMAYA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.